The AAPM 2021 educational program will be available in fall 2020. In the meantime browse 2020 meeting sessions and speakers to get a sense of the premier pain education offered during the AAPM Annual Meeting & Preconferences. Access recordings of past meeting sessions on demand.

8:00 AM–5:00 PM Wednesday, February 26

Pharmacologic Management of Pain: Expanding the Options, Improving Outcomes (001)

A recording of this preconference course is now available in the AAPM Education Center


The pharmacologic management of acute and chronic pain is an important aspect of most if not all clinicians’ daily practices. However, strategies aimed at optimizing the use of nonopioid analgesics while mitigating the potential risks associated with opioid use can be difficult to implement. This course will provide timely, useful, and practical information about the use of opioid and nonopioid analgesics to treat adults with acute and chronic pain. The growing and evolving controversy of the therapeutic application of cannabis and cannabis-related products is an additional question facing providers.

With pain management-leading faculty for numerous well-regarded institutions, this course will help the learner better integrate various medications from different pharmacologic classes in order to optimize a rational polypharmacy approach to managing chronic pain, including comorbid symptoms of depression, anxiety, and sleep disturbances and implementing evidence-based assessment and treatment strategies supported by recent guidelines to optimize appropriate opioid analgesic use while applying a patient-centered approach to mitigate the risks of abuse, misuse, addiction, and diversion. Strategies to help improve opioid tapering and managing opioid use disorder will be explored.


W. Michael Hooten & Steven Stanos

Opioid Pharmacology

Jeffrey Gudin

Do the Right Thing? Navigating the 3 R’s: Recommendations, Rules, and Regulations to Manage Patients on Chronic Opioid Therapy

Halena Gazelka

Opioid Tapering and Case Presentation

Charles Argoff

Anticonvulsants for Neuropathic Pain

James Watson

Analgesic Antidepressants for Chronic Pain

Ajay Wasan

Pharmacologic Management of Pain-Related Sleep Disruption

Ajay Wasan

Topical Analgesics for Acute and Chronic Pain

Steven Stanos

Muscle Relaxers

Steven Stanos

Arachnoiditis and Aberrant Drug-Related Behavior: Management and Treatment Options

W. Michael Hooten & Steven Stanos

Rapid Fire Pharmacotherapy Review

NSAIDs for Chronic Pain

Zachary McCormick


Charles Argoff

Ketamine for Acute and Chronic Pain

W. Michael Hooten

Anticoagulant Management in Pain Medicine

Zachary McCormick

Pharmacologic Management of Migraine Headache

James Watson

Cannabinoids: From Bench to Bedside to Dispensary

Pharmacology of the Cannabinoids

Mark Wallace

Regulatory Environment of Medical Cannabis

David Edwards

Integration of Medical Cannabis into Your Clinical Practice

Grace Forde

Medical Cannabis: Dosing, Dispensaries, and Quality Control

Michelle Sexton

Learning Objectives:

  • Apply the recent epidemiological evidence related to prescription opioid abuse and misuse, prescription opioid and heroin overdose deaths, and the risks associated with concomitant benzodiazepine use.
  • Review opioid analgesic medications to better understand the potential benefits and short-comings of abuse deterrent formulations.
  • Assess and interpret aberrant drug-related behaviors and integrate risk assessment tools/strategies into clinical practice.

Commercial Support:

The AAPM 2020 preconference course Pharmacologic Management of Pain: Expanding the Options, Improving Outcomes is supported in part by an educational grant from the following commercial supporters as of February 7, 2020: Collegium Pharmaceutical, Inc.

8:00 AM–3:30 PM Thursday, February 27

Integrating Behavioral Pain Medicine into Patient Care: Science, Practice, and Innovations (003)

A recording of this preconference course is now available on demand in the AAPM Education Center


A full-day behavioral pain medicine workshop with some of the most prominent experts in the field. Presentations feature the state of the science, practice, and innovations. Participants will acquire actionable assessment skills, knowledge across a range of key topics, practical handouts, resources and tip sheets on behavioral medicine integration. This workshop is suitable for medical professionals who wish to better understand salient factors impacting their patients with pain, as well as for mental health professionals who want more experience in pain treatment. Featured workshop speaker: Dr. Franke Keefe


Tim Lamer

Behavioral Pain Medicine: Challenges and Opportunities

Beth Darnall

Placebo and Expectations

Luana Colloca

Measurement of Highest Yield Psychological Factors

Daniel Bruns

Behavioral Interventions for Pain: Where Have We Been and Where Are We Going?

Francis Keefe

Treatment of Depression and Anxiety Disorders

Ajay Wasan

Diagnosing Addiction in Patients on Prescribed Opioids

Edward Covington

Yes, We Do That Too: The Many Roles for Pain Psychologists

Judith Scheman

Learning Objectives:

  • Discuss the role of psychological factors in the experience and treatment of pain.
  • List 3 novel future directions for behavioral pain medicine and list 2 key assessment tools for behavioral specialists who treat pain.
  • Discuss the role of placebo and nocebo in the experience and treatment of pain.
8:00 AM–3:30 PM Thursday, February 27

Advanced Ultrasound-Guided Pain Medicine Interventions (002)

The field of pain medicine ultrasonography is rapidly evolving with new applications for acute and chronic pain that can be rapidly applied to clinical practice. Ultrasound guidance offers the potential benefits of accuracy, portability, direct visualization of vasculature, absence of radiation exposure and potentially lower cost. With improving technology, emerging applications continue to evolve for pain medicine sonography.

This program provides an overview of the advantages and limitations of ultrasound guidance in the practice of pain medicine and provides hands-on applications for the ultrasound novice. The advantages and disadvantages of ultrasound and fluoroscopy also will be discussed. Attendees will practice real-time techniques for common ultrasound procedures and will review the available literature regarding new indications, safety and outcomes.

Attendees will rotate through live model hands-on stations with a low faculty-to-learner ratios covering treatments listed below. A limited number of reduced-price registrations will be offered for trainees currently enrolled in fellowship programs.


Head and Neck

Including third occipital nerve, cervical medial branch, cervical facet joint, TMJ, cervical selective nerve root block, stellate ganglion, occipital nerve, V2/V3, and US guidance for nerve ablation

David A. Edwards, MD PhD
Lynn Kohan, MD

Lumbar Spine, Sacrum, Pelvis

Including lumbar facet joint injection, lumbar medial branch, SI joint, SI joint denervation (posterior sacral network), caudal epidural, piriformis, iliopsoas bursa, IL/IH nerve, genitofemoral nerve, pudendal nerve, lateral femoral cutaneous nerve, US guidance for nerve ablation

Ming-Chi Kao, MD PhD
Vafi Salmasi, MD

Upper Extremity Musculoskeletal and Nerve

Including AC joint, glenohumeral joint, subacromial/subdeltoid bursa, biceps tendon, suprascapular nerve, cubital tunnel, carpal tunnel, US guidance for nerve ablation and brachial plexus blocks

James Khan, MD MSc
Jee Youn Moon, MD PhD FIPP CIPS

Lower Extremity

Including hip joint, knee joint, trochanteric bursa, saphenous nerve, common peroneal nerve at the fibular head, superficial peroneal nerve, deep peroneal nerve, tibial nerve, sural nerve, US guidance for nerve ablation

Tina Doshi, MD MHS
Christy Hunt, DO

Ultrasound Guidance for Peripheral Nerve Stimulation

Amitabh Gulati, MD
Eellan Sivanesan, MD

Ultrasound Guidance for Regenerative Medicine

Einar Ottestad, MD FIPP CIPS
Eugene Roh, MD

Learning Objectives:

  • Describe pain sonography spanning the head, neck, spine, pelvis, and upper and lower extremities.
  • Describe the utility of ultrasound guidance in ablation, peripheral nerve stimulation, and regenerative medicine interventions.
  • Recognize the limitations of spine sonography and the process of ultrasound-assisted vs. ultrasound-guided neuraxial injections.

The 2020 Advanced Ultrasound-Guided Pain Medicine Interventions preconference course is supported in part by in-kind durable equipment borrowed from the following companies as of February 14, 2020: Avanos, Clarius Mobile Health, GE Healthcare, Konica Minolta, Mark2 Medical, Inc., a Mindray Distributor; RGS Healthcare, Safersonic, SPR Therapeutics.


8-8:55 am
Rotation 1

8:55-9:50 am
Rotation 2

9:50-10 am

0-10:55 am
Rotation 3

10:55-11:50 am
Rotation 4

11:50 am-Noon

Noon-1:30 pm

1:30-2:25 pm
Rotation 5

2:25-3:10 pm
Rotation 6

3:10-3:15 pm
Q&A and closing remarks

8:00 AM–11:45 AM Thursday, February 27

Strategies for Effective Pain Management (Free REMS Course)

Free CME REMS course, Strategies for Effective Pain Management

Program Overview

These 3 sessions, compromised of six CME modules, comprise a REMS-compliant training program focused on the safe prescribing of opioid analgesics.

  • Pre and Post test questions for each module to be ran through the Audience Response System.
  • Attendees will also complete an assessment form confirming their completion of the training. 


  • Strategies for Effective Pain Management: The Basics
  • Strategies for Effective Pain Management: Individualizing Treatment
  • Strategies for Effective Pain Management: Managing Patients on Opioid Analgesics

Educational Objectives

Following participation in this session you will be able to:

  1. Increase prescribers’ knowledge of all options for pain management, including non-pharmacologic and pharmacologic approaches
  2. Improve prescribers’ knowledge of definitions and mechanisms of pain
  3. Increase prescribers’ understanding of appropriate pain assessment and assessment of potential risk factors for abuse and opioid use disorder/addiction
  4. Improve prescribers’ knowledge, competence and performance in the area of integrating opioids into individualized treatment plans to meet the needs of patients and managing those patients
  5. Help prescribers incorporate practices that facilitate the reduction of risks associated with prescription of opioid analgesics, as well as safe storage and disposal
  6. Improve prescribers’ skills in patient and caregiver counseling, including counseling about the use of naloxone for opioid overdose
  7. Help prescribers recognize opioid use disorder and act appropriately to treat or refer those patients


The nation is facing competing public health issues: the need to adequately treat a large number of Americans with acute and chronic pain, and a crisis of prescription opioid abuse. Pri-Med’s Strategies for Effective Pain Management curriculum focuses on improving practitioners’ ability to recognize, diagnose, and classify pain; educating providers on the full spectrum of pain management options, including non-opioid pharmacologic interventions; and providing risk reduction strategies through integration of opioids into individualized pain management plans. Clinicians will also learn to recognize signs and symptoms of opioid dependence and abuse to better manage patients’ pain and medication use. It is critically important that Clinicians have all the information they need to properly treat their patients and safely manage their pain.

This program is free. Advance registration is required.

CME Accreditation and Credit Designation Statements

Pri-Med Institute is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Pri-Med Institute designates this live activity for a maximum of 3.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Certificates of Credit/Attendance for the REMS Course will be provided to attendees by Pri-Med Institute.

MOCA 2.0® Credits

Physicians in the “Strategies for Effective Pain Management” symposium may receive MOCA 2.0® credit upon completion of the session evaluation. Pri-Med Institute will report participant completion data to the American Board of Anesthesiology via the ACCME’s Program and Activity Reporting System (PARS) on behalf of the participant.

Maintenance of Certification in Anesthesiology™ program and MOCA 2.0® are registered trademarks of The American Board of Anesthesiology®. This activity contributes to the CME component of the American Board of

Anesthesiology’s redesigned Maintenance of Certification in Anesthesiology™ (MOCA®) program, known as MOCA 2.0®. Please consult the ABA website,, for a list of all MOCA 2.0 requirements.

ABPMR MOC Part II Lifelong Learning

Physicians in the “Strategies for Effective Pain Management” symposium will receive a CME credit certificate upon completion of the session evaluation, AMA PRA Category 1 Credit™ can be applied toward ABPMR MOC Part II Lifelong Learning CME credit; participants will need to report these CME credits directly into their ABPMR MOC Homepage.

State-Required CME

This activity satisfies topic-specific CME requirements (pain management, controlled substances, etc) of many

state licensing boards. Please check with your state’s licensing boards for specific requirements.


Completion of this accredited CME activity meets the expectations of an Accredited Safety or Quality Improvement

Program (IA_PSPA_28) for the Merit-based Incentive Payment Program (MIPS).

Clinicians who are eligible for the Merit-based Incentive Payment System (MIPS) can report participation in this CME activity as an Improvement Activity. This is a Medium weighted activity, in the Patient Safety and Practice Assessment sub-category. For group reporting (during CY 2020), a group or virtual group can attest to an activity when at least 50% of the clinicians in the group or virtual group perform the same activity during any continuous 90-day period (or as specified in the activity description) in the same performance year. For more information, visit

This REMS symposium will be available on-demand at in late March, to achieve 50% participation in your group.

This activity is supported by an independent educational grant from the Opioid Analgesic REMS Program Companies. Please see for a listing of REMS Program Companies. This activity is intended to be fully compliant with the Opioid Analgesic REMS education requirements issued by the US Food and Drug Administration (FDA).


Subscribe to this RSS feed